scispace - formally typeset
Journal ArticleDOI

Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome.

Reads0
Chats0
TLDR
Three new patients compared to previous cases, highlighted that despite two critical regions, both distal deletion at 2p16.1 and proximal deletion at2p15 are associated with phenotypes that are very close to each other.
Abstract
Interstitial 2p15p161 microdeletion is a rare chromosomal syndrome previously reported in 33 patients It is characterized by intellectual disability, developmental delay, autism spectrum disorders, microcephaly, short stature, dysmorphic features, and multiple congenital organ defects It is defined as a contiguous gene syndrome and two critical regions have been proposed at 2p15 and 2p161 loci Nevertheless, patients with deletion of both critical regions shared similar features of the phenotype and the correlation genotype–phenotype is still unclear We review all published cases and describe three additional patients, to define the phenotype–genotype correlation more precisely We reported on two patients including the first prenatal case described so far, carrying a 2p15 deletion affecting two genes: XPO1 and part of USP34 Both patients shared similar features including facial dysmorphism and cerebral abnormalities We considered the genes involved in the deleted segment to further understand the abnormal phenotype The third case we described here was a 4-year-old boy with a heterozygous de novo 427 kb deletion encompassing BCL11A and PAPOLG at 2p161 He displayed speech delay, autistic traits, and motor stereotypies associated with brain structure abnormalities We discuss the contribution of the genes included in the deletion to the abnormal phenotype Our three new patients compared to previous cases, highlighted that despite two critical regions, both distal deletion at 2p161 and proximal deletion at 2p15 are associated with phenotypes that are very close to each other Finally, we also discuss the genetic counseling of this microdeletion syndrome particularly in the course of prenatal diagnosis

read more

Citations
More filters
Journal ArticleDOI

Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity.

TL;DR: Analysis of ~10,000 cases of developmental delay and autism identifies 253 candidate neurodevelopmental disease genes with an excess of missense and/or likely gene-disruptive mutations and highlights cell-specific enrichments of disease-related genes in the D1+ and D2+ spiny neurons of the striatum.
Journal ArticleDOI

The ASD Living Biology: from cell proliferation to clinical phenotype

TL;DR: The first such study is reviewed, which confirms the multistage fetal nature of ASD and provides the first in vitro fetal-stage explanation for in vivo early brain overgrowth.
Journal ArticleDOI

Ubiquitin-Specific Protease 34 Inhibits Osteoclast Differentiation by Regulating NF-κB Signaling.

TL;DR: Results show that USP34 inhibits osteoclastogenesis by regulating NF‐κB signaling by deubiquitinating and stabilizing the NF-κB inhibitor alpha (IκBα) and represses osteoclastic hyperfunction of Usp34‐deficient RAW264.7 cells.
Journal ArticleDOI

Aetiology of childhood apraxia of speech: A clinical practice update for paediatricians.

TL;DR: Childhood apraxia of speech requires careful differential diagnosis from other childhood speech disorders, but when a severe and persistent diagnosis is confirmed, a genetic aetiology should increasingly be pursued.
Journal ArticleDOI

Genome-wide association study of musical beat synchronization demonstrates high polygenicity

TL;DR: In this article , a genome-wide association study was conducted to identify common genetic variants associated with beat synchronization in 606,825 individuals, with 69 loci reaching genomewide significance (P < 5 × 10-8) and single-nucleotide-polymorphism-based heritability of 13-16%.
References
More filters
Journal ArticleDOI

CRM1-mediated nuclear export: to the pore and beyond.

TL;DR: Besides its established role in nuclear export, CRM1 is also implicated in various steps during mitosis, widening its functional spectrum within the cell.
Journal ArticleDOI

The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.

TL;DR: BCL 11A coamplified with REL in B-NHL cases and HD lymphoma cell lines with gains and amplifications of 2p13, suggesting that BCL11A may be involved in lymphoid malignancies through either chromosomal translocation or amplification.
Journal ArticleDOI

Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes

TL;DR: This review provides the first comprehensive classification of the clinical and genetic features of syndromes associated with callosal agenesis, and provides a genetic and developmental framework for the interpretation of future research that will guide the next advances in the field.
Journal ArticleDOI

BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations

TL;DR: The study of 3 patients with rare microdeletions of 2p15-p16.1 who presented with an autism spectrum disorder and developmental delay and orthogonal genetic data demonstrates that BCL 11A plays a central role in silencing HbF in humans and implicates BCL11A as an important factor for neurodevelopment.
Related Papers (5)